Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):9–17. doi: 10.1158/1055-9965.EPI-09-0777

Table 1.

Clinical characteristics of men with diabetes at the time of radical prostatectomy stratified by race and obesity categories

Diabetic at surgery Not diabetic at
surgery
p value*
No of patients (%) 233 (19) 1029 (82)
Age in years at surgery 0.82
 Mean ± SD 61.6 ± 5.5 61.4 ± 6.5
 Median (Range) 62 (43 - 74) 61 (43 - 86)
Median year of surgery 2003 2001 <0.001
PSA in ng/mL
 Mean ± SD 7.9 ± 6.1 9.5 ± 9.0 0.01
 Median (Range) 6.2 (0.9 - 59.3) 7.1 (0.1 - 140 )
Obesity in kg/m2 no (%) <0.001
 Normal weight (<25) 38 (16) 280 (27)
 Overweight (25 to 29.9) 92 (39) 484 (47)
 Mildly obese (30 to 34.9) 71 (30) 196 (19)
 Moderately and Severely Obese (>35) 32 (14) 69 (7)
Race no (%) 0.003
 White 103 (44) 567 (55)
 Black 130 (56) 462 (45)
Biopsy Gleason Score no (%) 0.07
 2-6 128 (55) 650 (63)
 7 61 (26) 220 (21)
 8-10 44 (19) 159 (16)
Clinical Stage no (%) 0.4
 T1 137 (59) 573 (56)
 T2 and above 96 (41) 456 (44)
Pathological Gleason Score no (%) <0.001
 2-6 59 (26) 416(41)
 3+4 111 (48) 400 (39)
 ≥4+3 61 (26) 205 (20)
ECE no (%) 51 (22) 194 (19) 0.3
SVI no (%) 29 (13) 88 (9) 0.07
PSM no (%) 110 (48) 447 (44) 0.3
LNI no (%) 3 (34) 17 (26) 0.04

ECE – extracapsular extension, PSM – positive surgical margins SVI – seminal vesicle invasion LNI – lymph node involvement

*

p value assessed by chi squared test unless otherwise specified

p value assessed by rank sum test